Synthego

CRISPR gene editing
#Business #CRISPR #Synthego

CRISPR solutions company declares bankruptcy

Synthego, a supplier of CRISPR solutions, has entered into a purchase agreement with Perceptive Advisors to acquire all the assets of the company on a going-concern basis.   To facilitate the sale, the company has voluntarily initiated a Chapter 11 proceeding in the United States Bankruptcy Court of the District of… Read More

#Business & Investment #News

#CRISPR #Synthego

CRISPR revolution in cell and gene therapy

This paid-for advertorial by Synthego appeared in Volume 23 – Issue 4, Fall 2022. Rise of CRISPR-mediated Therapies After more than two decades of successes and failures, the promise of cell and gene therapy to treat the root cause of many human diseases is now starting to redefine modern medicine. Read More

#Exclusive Content